Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

UroGen Pharma Ltd. announced the launch of its LG-UTUC Luminaries initiative which recognizes clinicians and institutions demonstrating leadership in treating low-grade upper tract urothelial cancer (LG-UTUC), a rare and recurrent form of cancer. The program aims to promote kidney-sparing treatment approaches and foster collaboration among urology …

Gold.com, Inc. Increases Share Repurchase Program

Gold.com, Inc. Increases Share Repurchase Program

Gold.com, Inc. announced an increase in its authorized share repurchase program, allowing it to buy back up to 2 million additional shares on top of the 1.3 million shares already repurchased. The company cites confidence in its business strength and long-term value generation, and the buyback will be executed based on market conditions and strateg…

Costco Wholesale Corporation Reports March Sales Results

Costco Wholesale Corporation Reports March Sales Results

Costco Wholesale Corporation announced net sales of $28.41 billion for the retail month of March 2026, representing an 11.3% increase compared to last year. For the first 31 weeks, net sales rose 9.1% to $173.26 billion. Comparable sales growth was driven by strong performance in all regions, notably digitally-enabled sales, which grew over 20%. Th…

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

OPKO Health's subsidiary, ModeX Therapeutics, has initiated a Phase 1 clinical trial evaluating MDX2301, a tetravalent bispecific antibody designed to neutralize all known SARS-CoV-2 variants, to prevent COVID-19. This first-in-human study focuses on safety, tolerability, and pharmacokinetics across different administration routes in healthy and hi…

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

AVITA Medical has secured a 10-year agreement with the U.S. government's BARDA valued at up to $25.5 million to provide rapid access to its RECELL technology for burn mass casualty incidents. The contract includes maintaining inventory and readiness to deploy up to 3,000 units nationwide, supporting national preparedness and emergency response capa…

Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

Pacira BioSciences announced its participation in a virtual fireside chat at the 25th Annual Needham Virtual Healthcare Conference and disclosed inducement stock awards granted to new employees under its Inducement Plan, including stock options and restricted stock units with scheduled vesting. The company highlighted its commitment to innovative n…

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

Amarin Corporation highlights the pivotal role of icosapent ethyl (IPE) in addressing elevated triglycerides and residual cardiovascular risk, as presented at the ACC Scientific Sessions 2026. Supporting new analyses from the REDUCE-IT trial and updated 2026 ACC/AHA guidelines underscore the need for complementary therapies beyond statins. IPE demo…

Sunrun Announces Date for First Quarter 2026 Earnings Report

Sunrun Announces Date for First Quarter 2026 Earnings Report

Sunrun Inc., a leading provider of home solar and battery storage solutions, announced it will report its first quarter 2026 earnings after market close on May 6, 2026, followed by a conference call at 1:30 p.m. Pacific Time. The company invites investors and analysts to join the call via their website or phone, with replay and transcript available…

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Cue Biopharma announced it will receive a $7.5 million preclinical milestone payment from Boehringer Ingelheim following the selection and approval of its first compound for lead optimization. This milestone validates the progress of Cue Biopharma's collaboration to develop innovative therapeutics for autoimmune and inflammatory diseases leveraging…

Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2026 Earnings Release and Conference Call

Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2026 Earnings Release and Conference Call

Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) announced that it will release its first quarter 2026 financial results after market close on April 28, 2026, followed by a conference call on April 29 to discuss performance and recent events. The company is a real estate investment trust specializing in commercial real estate debt investment…